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Abstract
Pseudomonas aeruginosa is an opportunistic pathogen that can cause severe infections at
compromised epithelial surfaces, such those found in burns, wounds, and in lungs dam-
aged by mechanical ventilation or recurrent infections, particularly in cystic fibrosis (CF) pa-
tients. CF patients have been proposed to have a Th2 and Th17-biased immune response
suggesting that the lack of Th1 and/or over exuberant Th17 responses could contribute to
the establishment of chronic P. aeruginosa infection and deterioration of lung function. Ac-
cordingly, we have observed that interferon (IFN)-γ production by peripheral blood mononu-
clear cells from CF patients positively correlated with lung function, particularly in patients
chronically infected with P. aeruginosa. In contrast, IL-17A levels tended to correlate nega-
tively with lung function with this trend becoming significant in patients chronically infected
with P. aeruginosa. These results are in agreement with IFN-γ and IL-17A playing protective
and detrimental roles, respectively, in CF. In order to explore the protective effect of IFN-γ in
CF, the effect of IFN-γ alone or in combination with granulocyte-macrophage colony-stimu-
lating factor (GM-CSF), on the ability of human macrophages to control P. aeruginosa
growth, resist the cytotoxicity induced by this bacterium or promote inflammation was inves-
tigated. Treatment of macrophages with IFN-γ, in the presence and absence of GM-CSF,
failed to alter bacterial growth or macrophage survival upon P. aeruginosa infection, but
changed the inflammatory potential of macrophages. IFN-γ caused up-regulation of mono-
cyte chemoattractant protein-1 (MCP-1) and TNF-α and down-regulation of IL-10 ex-
pression by infected macrophages. GM-CSF in combination with IFN-γ promoted IL-6
production and further reduction of IL-10 synthesis. Comparison of TNF-α vs. IL-10 and IL-6
vs. IL-10 ratios revealed the following hierarchy in regard to the pro-inflammatory potential
of human macrophages infected with P. aeruginosa: untreated< treated with GM-CSF<
treated with IFN-γ< treated with GM-CSF and IFN-γ.
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Introduction
Pseudomonas aeruginosa is an opportunistic, Gram-negative bacterial pathogen that poses a se-
rious healthcare challenge. It can colonise and adapt to many different environments due to its
versatile metabolism and ability to form biofilms and produce a wide range of virulence factors
[1,2]. Cystic fibrosis (CF) patients are especially susceptible to chronic, often fatal, respiratory
infections caused by P. aeruginosa [3] with this bacterium being considered the primary cause
of morbidity and mortality in the CF population [4].
In CF patients, high systemic and pulmonary expression of the T helper cell 2 (Th2) cyto-
kine interleukin 4 (IL-4) correlates with chronic P. aeruginosa infection and poor pulmonary
function, while high expression of the Th1 cytokine interferon-γ (IFN-γ) correlates with im-
proved pulmonary function [5–7]. Infections using animal models also show that IFN-γ or a
Th1 bias is protective in P. aeruginosa respiratory infections [8,9]. It is widely accepted that
macrophages present during Th1 and Th2 responses differ greatly: IFN-γ induces M1/classical-
ly activated macrophages, which are highly phagocytic, microbicidal against intracellular path-
ogens, and pro-inflammatory, while the Th2 cytokines IL-4 and IL-13 induce M2/alternatively
activated macrophages, which are much less microbicidal and inflammatory [10,11]. CF pa-
tients infected with P. aeruginosa have a higher percentage of M2 macrophages in their lungs
than those who are not and this inversely correlates with lung function [12]. In line with this,
CF patients infected with P. aeruginosa who are on azithromycin, a drug shown to induce M2
macrophage activation, present a very high percentage of M2 macrophages and very poor lung
function [12] [13].
Recently, CF patients have also been shown to display a Th17-biased immune response that
could contribute to deterioration of lung function [14–17] with one report highlighting the co-
existence of Th17 and Th2 cytokine profiles in CF [18]. IL-17A is important for protection
against extracellular bacterial and fungal pathogens, particularly in mucosal tissue [19]. In par-
ticular, IL-17A promotes the generation, recruitment, and activation of neutrophils by induc-
ing the expression of: (i) the colony-stimulating factors: granulocyte colony-stimulating factor
(G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF), and (ii) the che-
mokines: IL-8, growth-related oncogene α (GRO-α), and granulocyte chemotactic protein 2
(GCP-2) [20]. It has been suggested that overproduction of IL-17A may drive chronic pulmo-
nary inflammation in CF [21].
Macrophages play important roles both as immunomodulatory cells that influence inflam-
matory responses and as effector cells that phagocytose and kill pathogens [22]. Numerous
studies have demonstrated that human and murine macrophages phagocytose P. aeruginosa
[23–25] and that murine macrophages produce cytokines and chemokines in response to P.
aeruginosa or its products [26,27]. An important consideration is how macrophage activation
affects responses to P. aeruginosa.
The study presented in this manuscript shows that IFN-γ production by peripheral blood
mononuclear cells (PBMCs) from CF patients positively correlates with lung function, whereas
the opposite is the case for IL-17A production. We hypothesised that IFN-γ could be protective
in CF by modifying the response of macrophages to P. aeruginosa infection which in turn
could affect the inflammatory response in the infected lung. To test this, the effect of IFN-γ on
the interaction of P. aeruginosa with primary human macrophages from healthy donors was
investigated. GM-CSF was also used to treat macrophages because: (i) it has an activating effect
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on myeloid cell function [28,29]; (ii) it has therapeutic potential in CF [30]; (iii) high serum
GM-CSF levels correlate with increased IFN-γ expression and better pulmonary function in CF
patients [6], and (iv) GM-CSF complements IFN-γ in macrophage resistance to mycobacterial
infection [31], strongly suggesting that the two factors may co-operate in host defence.
Our results show that IFN-γ in the presence and absence of GM-CSF does not alter the abili-
ty of human macrophages to control P. aeruginosa growth or improve macrophage survival
during infection. IFN-γ promotes the pro-inflammatory response of human macrophages to P.
aeruginosa infection by increasing the TNF-α vs IL-10 and IL-6 vs IL-10 ratios and these effects
are enhanced by GM-CSF. This study provides further information on what constitutes a bene-
ficial immune response against P. aeruginosa in humans and how cytokine(s)-based immuno-
therapy [32] could influence effector immune responses against this pathogen.
Materials and Methods
Ethics statement
Study using two groups of CF patients and control PBMCs was approved by the Nottingham
University Hospital NHS Trust Research and Development (ID: 09RM001) and the University
of NottinghamMedical School Research Ethics Committee (Ethics Reference No:
BT28092010), respectively. All donors provided informed written consent and samples
were anonymised.
CF patients and controls
Study subjects were 18 years old. In the present study, CF patients were divided in two
groups to compare those with chronic P. aeruginosa infection (referred to in this study as CF/
Chronic PA) versus those with intermittent infection or free of infection (referred to in this
study as CF/Intermittent-Free PA). P. aeruginosa infection status was defined according to the
Leeds criteria [33]. CF patients were clinically stable and not on intravenous antibiotics at the
time of the study. Healthy volunteers were age-, sex-, and ethnicity-matched to patients had no
history of respiratory disease, were not suffering from infection or on medication at the time of
sample collection. See Table 1 for demographic details for CF patients, including classification
criteria, and matched healthy controls utilised in the present study.
Assessment of lung function
Spirometry was performed using a micro-medical microlab (ML 3500) spirometer according
to the joint ERS/ATS criteria [34].
Preparation of PAO1-L lysates for PBMC stimulation
The strain of P. aeruginosa PAO1, subline Lausanne (PAO1-L), was used throughout this
study. PAO1 is a serogroup O2/O5, type b flagellated strain [33,34] exhibiting moderate viru-
lence [35]. The genome of PAO1-L has been fully sequenced and found closest to Holloway’s
original isolate (data not shown) [36,37]. Mid-log phase cultures of PAO1-L (3 hour, h) in
Luria-Bertani (LB) broth were washed with PBS without Ca2+ or Mg2+ (Sigma-Aldrich), resus-
pended in RPMI-1640 without phenol red (Sigma-Aldrich) such that cultures were 20x con-
centrated, and lysed using a French Press. Lysates were centrifuged to remove debris, filtered
through a 0.2 μm filter, aliquoted, snap frozen on dry ice, and stored at -80°C until used. Total
protein content in lysates was quantified using the bicinchoninic acid assay (Thermo
Scientific).
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PBMC stimulation and culture
Venous blood was collected in EDTA vacutainers (BD Diagnostics-Preanalytical Systems), the
plasma was removed, and cells were processed within 24 h. 2 x 105 PBMCs in 100 μl/well were
cultured in RPMI-1640 containing 10% human AB serum, 2 mM L-glutamine, 100 U/ml peni-
cillin, 100 μg/ml streptomycin, and 10 mMHEPES in 96-well U-bottom tissue culture plates
(Corning Life Sciences) and stimulated with 2% (v/v) phytohaemagglutinin (PHA, M-form,
Invitrogen), 10 ng/ml staphylococcal enterotoxin B (SEB, Sigma-Aldrich) or two concentra-
tions (6,250 ng/ml and 24 ng/ml total protein) of two independently prepared PAO1-L lysates
at 37°C, 5% CO2 for 6 days. On Day 6 PBMCs were re-stimulated with 15 ng/ml phorbol 12-
myristate 13-acetate (PMA, Sigma-Aldrich) overnight, and supernatants harvested for cytokine
analysis on Day 7.
Generation and activation of monocyte-derived macrophages
PBMCs were isolated from buffy coats (Blood Transfusion Service, Sheffield, UK) by Histopa-
que-1077 (Sigma-Aldrich) density gradient centrifugation, and monocytes purified using human
CD14MicroBeads and LSMACS columns (Miltenyi Biotec). Monocytes were cultured in Teflon
bottles (Nalgene, Fisher Scientific, 107 monocytes/ bottle) in RPMI-1640 (Sigma-Aldrich) con-
taining 15% human AB serum (Sigma-Aldrich or PAA Laboratories Ltd), 2 mM L-glutamine,
100 U/ml penicillin, 100 μg/ml streptomycin (Sigma-Aldrich), 10 mMHEPES (Invitrogen), and
50 ng/ml human macrophage colony-stimulating factor (M-CSF, R&D Systems) at 37°C, 5%
CO2 for 7 days. Fresh medium containing 50 ng/ml M-CSF was added on Day 3. Macrophages
expressed the expected surface markers (S1A and B Fig.) and generated oxidative burst products
in response to zymosan (S1C Fig.). On Day 7, macrophages were plated on 24-well tissue culture
plates (Corning Life Sciences) at 2.5 x 105 macrophages per well in X-Vivo 15 (Lonza) with M-
CSF (50 ng/ml) or GM-CSF (50 ng/ml, Miltenyi Biotec), in the presence and absence of IFN-γ
(200 U/ml = 10 ng/ml, R&D Systems) and cultured at 37°C, 5% CO2 for 48 h.
Table 1. Demographic details for CF patients and matched healthy controls utilised in the present study.
Healthy
controls
CF/Chronic PA CF/Intermittent-Free PA
Number (n) 13 15 15
Intermittent n = 2
Free n = 11
Never n = 2
Classiﬁcation
criteria [33]
N/A Chronic: > or = 50% of cultures positive for P.
aeruginosa in past 12 months
Intermittent: <50% cultures positive for P. aeruginosa in
past 12 months
Free: P. aeruginosa not isolated in past 12 months but has
been isolated prior to this study
Never: P. aeruginosa never isolated
Sex (F/M) 6/7 6/9 8/7
Mean age ± SD
(years)
29.6 ± 4.8 27.7 ± 8.1 27.5 ± 11.4
Genotype N/A ΔF508 homozygous: 6 ΔF508 homozygous: 7
ΔF508 heterozygous: 4 ΔF508 heterozygous: 2
Other: 2 Other: 1
Unknown: 3 Unknown: 5
F, female; M, male; SD, standard deviation; N/A, not applicable.
doi:10.1371/journal.pone.0117447.t001
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Inocula preparation
To avoid potential interference from microbe-associated molecular patterns (MAMPs) and
danger-associated molecular patterns (DAMPs) [35] contained in commonly used bacterial
growth media such as LB broth, P. aeruginosa inocula were grown and prepared in the same
serum-free medium (X-Vivo 15) in which the infections were performed. P. aeruginosa growth
and expression of key quorum sensing regulatory genes and quorum sensing controlled genes
encoding virulence factors in X-Vivo 15 were evaluated and found suitable for the study (S2
and S3 Figs. and S1 Table). P. aeruginosa strain PAO1-L from glycerol stocks was streaked on
to an LB agar plate and incubated at 37°C overnight. The following day a single colony was in-
oculated into 5 ml of X-Vivo 15 and incubated overnight at 37°C, 200 rpm. The overnight cul-
ture was adjusted to OD600nm = 1, diluted 1:100 in 25 ml of fresh X-Vivo 15 in a 250 ml flask,
and incubated at 37°C, 200 rpm for 3 h. This 3 h culture was washed twice with cold PBS with-
out Ca2+ or Mg2+, resuspended in X-Vivo 15, counted using a Thoma bacterial counting cham-
ber (Hawksley) and a Nikon Eclipse TE200 microscope, and the density of the culture adjusted
to achieve a multiplicity of infection (MOI) = 1.
Macrophage infection
Macrophages plated in 24-well plates were washed three times with cold PBS without Ca2+ or
Mg2+. PAO1-L mid-log phase inoculum containing the appropriate cytokine(s) was then
added to the wells (MOI = 1, 350 μl inoculum per well) and cultures were incubated at 37°C,
5% CO2 for up to 6 h. Since P. aeruginosa is mainly an extracellular pathogen, non-internalised
bacteria were maintained throughout the course of the infection. Controls were uninfected
macrophages treated with the same cytokines, and bacteria only cultures—wells that contained
the PAO1-L inoculum with the appropriate cytokine(s) but no macrophages. To measure the
macrophage-associated bacteria, macrophages were lysed by adding cold ultra-pure distilled
water (Invitrogen). Appropriate dilutions of the macrophage supernatants and lysates and bac-
teria only controls were prepared in PBS and plated on LB agar plates and incubated at 37°C
overnight to determine viable cfu. Both extracellular and macrophage-associated bacteria were
expressed as a percentage of the bacteria only controls for that time point.
Quantification of macrophage cytotoxicity
Lactate dehydrogenase (LDH) activity was measured using the Cytotoxicity Detection Kit
(Roche Applied Science) as per the manufacturer’s instructions. A standard curve prepared
from an LDH positive control (Promega) was used to calculate the LDH concentration in sam-
ples. Lysates of macrophages prepared using 0.1% Triton X-100 were used as 100% lysis con-
trols. Bacterial contribution to LDH readings was negligible (S4 Fig.)
Microscopic assessment of infected macrophages
Day 7 macrophages plated on sterile, acid-etched coverslips were activated and infected as de-
scribed above. At the required time points post-infection supernatants were removed and cells
fixed in 4% paraformaldehyde (Electron Microscopy Science) in PBS. Fixed samples were
stained using the Hemacolor Staining Kit (Merck Millipore) as per the manufacturer’s instruc-
tions, mounted on slides using DPX mounting medium (Raymond A Lamb Laboratory Sup-
plies), viewed using a Zeiss Axioplan light microscope, and images captured with a Q Imaging
MicroPublisher 5.0 RTV camera and Openlab software.
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Cytokine quantification
Cytokines and chemokines in supernatants from PBMC stimulation assays and macro-
phages infection assays were quantified using the FlowCytomix bead-based assay
(eBioscience). Supernatants had to be diluted 1:10 in order to measure TNF-α and IL-18
accurately as these cytokines were produced at quantities that exceeded the standard range
of the respective cytokine kits. Results were analysed using the eBioscience FlowCytomix
Pro 2.4 software.
Statistical analysis
Statistical analyses were performed in GraphPad Prism v 6.02. For CF and healthy control
PBMC cytokine responses significance was calculated using Kruskal-Wallis test with Dunn’s
post test. Correlations between CF pulmonary function and cytokine responses were calculated
by Spearman rank test. For macrophage experiments significance was calculated by one-way
ANOVA with Tukey’s post test (for unpaired data) or repeated measures one-way ANOVA
with Tukey’s or Dunnett’s post test (for paired data). LDH release at different times post-
infection was analysed using a paired Student’s t test. p0.05 was considered significant in
all cases.
Results
IFN-γ and IL-17A production by stimulated PBMC cultures from CF
patients and healthy controls
Previous studies have demonstrated attenuated IFN-γ or Th1 responses and enhanced IL-17A
or Th17 responses in CF patient peripheral blood and lungs [5–7,14–18], however they did not
establish whether there were any differences in these responses between patients chronically or
intermittently infected with P. aeruginosa. Therefore, in this study the production of IFN-γ
(Fig. 1A), IL-17A (Fig. 1B), IL-13 and IL-10 (S5 Fig.) in an independent CF population consist-
ing of patients with either chronic or intermittent/free P. aeruginosa infections (CF/Chronic
PA and CF/Intermittent-Free PA, respectively) was investigated. PBMCs from CF patients and
healthy controls were stimulated as described in materials and methods with the mitogen phy-
tohaemagglutinin, PHA, the superantigen staphylococcal enterotoxin B,SEB, and two doses of
P. aeruginosa (PAO1-L) lysates (PA Hi and PA Lo) (See Table 1 for demographic details for pa-
tients and healthy volunteers). P. aeruginosa lysates were selected as stimuli because CF pa-
tients were stratified based on chronicity of P. aeruginosa infection in this study and similar
preparations have previously been used by other authors [18]. The overall IFN-γ production
was reduced by approximately 1.5 to 2-fold in both groups of CF patients as compared to
healthy controls when PBMCs were stimulated with PHA or SEB (Fig. 1A). For CF/Chronic
PA patients, this attenuation was significant in response to both PHA (p = 0.0014) and SEB (p
= 0.0356), while for CF/Intermittent-Free PA patients, it was only significant in response to
SEB (p = 0.0386). Levels of IL-17A were also consistently reduced in CF PBMC cultures com-
pared to healthy controls (Fig. 1B). The IL-17A reduction was significant for CF/Chronic PA
patients in response to SEB (p = 0.0007) and PA Hi (p = 0.0386), and for CF/Intermittent-Free
PA patients in response to PHA (p = 0.0420), SEB (p = 0.0096), PA Hi (p = 0.0292) and PA Lo
(p = 0.0137). The production of IL-13 and IL-10 was not consistently reduced in the CF sam-
ples (S5 Fig.) which argues against the attenuation in IFN-γ and IL-17A production being due
to greater cell death in these PBMC cultures.
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Correlation between IFN-γ and IL-17A production by stimulated PBMC
cultures and lung function in CF patients
To ascertain the potential clinical relevance of the levels of IFN-γ and IL-17A produced by
stimulated CF PBMCs, their possible correlation with pulmonary function in these patients
Fig 1. Production of IFN-γ and IL-17A in CF and control PBMCs in response to several stimuli. PBMCs were stimulated with 2% (v/v)
phytohaemagglutinin (PHA), 10 ng/ml staphylococcal enterotoxin B (SEB), or two concentrations of PAO1-L lysates—PA Hi (6,250 ng/ml total protein) and
PA Lo (24 ng/ml total protein)—for 6 days, re-stimulated with 15 ng/ml phorbol 12-myristate 13-acetate (PMA) overnight, and supernatants collected on day 7
for cytokine analysis.A. CF patient PBMCs produced less IFN-γ than healthy control PBMCs in response to PHA and SEB, but not PAO1-L lysates. B. CF
patient PBMCs produced less IL-17A than healthy control PBMCs in response to PHA, SEB and PAO1-L lysates. Graph depicts 5–95 percentile with
median; healthy controls: n = 13, CF/Chronic PA and CF/Intermittent-Free PA: n = 15 each. Significance calculated by Kruskal-Wallis test with Dunn’s post
test; * = p0.05, ** = p0.01, *** = p0.001.
doi:10.1371/journal.pone.0117447.g001
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was studied. When the CF patients were considered as a single population, a highly significant
positive correlation was observed between pulmonary function (measured as forced expiratory
volume in one second, FEV1) and IFN-γ production by PBMCs in response to PHA (Fig. 2A)
(IFN-γ vs. FEV1 (L): r = 0.5809, p = 0.0019; IFN-γ vs. % predicted FEV1: r = 0.5138, p =
0.0061). CF/Intermittent-Free PA patients had significantly better lung function than
Fig 2. Correlation between IFN-γ and IL-17A production by PHA-stimulated PBMC cultures and lung function in CF patients. A. Highly significant
positive correlation was observed between IFN-γ production in response to phytohaemagglutinin (PHA) and lung function in CF patients as measured by
absolute and % predicted forced expiratory volume in one second (FEV1). A trend towards a negative correlation was observed between IL-17A production in
response to PHA and lung function in CF patients as measured by absolute and % predicted FEV1. B. Significant positive correlation between IFN-γ
expression by CF/Chronic PA PBMCs in response to PHA with lung function as measured by absolute and % predicted FEV1. Significant negative correlation
between IL-17A expression by CF/Chronic PA PBMCs in response to PHA with lung function as measured by % predicted FEV1. CF/Chronic PA: n = 14 (as
lung function data was not available for 1 of the 15 CF/Chronic PA patients), CF/Intermittent-Free PA: n = 12 (as lung function data was not available for 3 of
the 15 CF/Intermittent-Free PA patients). Spearman test was used to determine correlation; * = p0.05, ** = p0.01.
doi:10.1371/journal.pone.0117447.g002
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CF/Chronic PA patients (S6 Fig.), and when both groups of CF patients were analysed sepa-
rately, the correlation between IFN-γ production in response to PHA and lung function only
remained significant in the case of CF/Chronic PA patients (Fig. 2B; S7 Fig.) (CF/Chronic PA
patients, IFN-γ vs. FEV1 (L): r = 0.6484, p = 0.0144; IFN-γ vs. % predicted FEV1: r = 0.6201,
p = 0.0157). A positive, significant correlation between levels of IFN-γ produced by CF/Chron-
ic PA PBMCs in response to PA Hi and FEV1 (absolute, r = 0.5611, p = 0.0394 and % predicted,
r = 0.5256, p = 0.0465) was also observed. Levels of IFN-γ in response to PA Lo did not corre-
late with lung function (data not shown).
In the case of IL-17A, a trend towards a negative correlation between IL-17A levels in re-
sponse to PHA and lung function was observed when the CF patients were considered as a sin-
gle population (Fig. 2A), and this trend became significant only when CF/Chronic PA patients
were considered and FEV1 was expressed as % predicted (Fig. 2B; S8 Fig.) (CF/Chronic PA pa-
tients, IFN-γ vs. % predicted FEV1: r = -0.552, p = 0.0341). IFN-γ and IL-17A production in re-
sponse SEB and IL-17A production in response to PA lysates did not correlate with lung
function (data not shown).
These results are consistent with an association between chronic P. aeruginosa infection and
poor lung function in CF patients, and with a protective role for IFN-γ and a detrimental role
for IL-17A in CF, particularly when lung function declines.
Pro-inflammatory response of human macrophages to P. aeruginosa
infection
The protective role of IFN-γ in CF led to investigate how this cytokine could assist in the main-
tenance of lung function in the context of P. aeruginosa infection. Given that macrophage acti-
vation appears to correlate with P. aeruginosa infection status and lung function in CF patients
[12], the impact of IFN-γ treatment on the interaction of healthy human macrophages with P.
aeruginosa was investigated. Towards this aim, the response of untreated macrophages to P.
aeruginosa infection was studied in the first instance. Human macrophages were infected at
MOI = 1 as described in materials and methods and the following parameters were analysed at
2, 4, and 6 hours post-infection (hpi): cytokine production by macrophages, bacterial cfu both
in the supernatants and cell-associated fraction, and macrophage death.
Several cytokines and chemokines were quantified in supernatants to obtain a general over-
view of the type of inflammatory response elicited by live P. aeruginosa in human macro-
phages. These include chemoattractants for neutrophils (IL-8, also termed CXCL8) and
monocytes (MCP-1 and MIP-1α, also termed CCL2 and CCL3, respectively) and pro-inflam-
matory (TNF-α, IL-6, IL1-β and IL-18) and anti-inflammatory (IL-10) cytokines (Fig. 3). IL-8
and MCP-1 were found to be constitutively expressed by uninfected macrophages and their
levels increased upon P. aeruginosa infection, at which time MIP-1α production was also de-
tected (Fig. 3A). PAO1-L infection stimulated a rapid and vigorous cytokine response in mac-
rophages (Fig. 3B). In addition to TNF-α and IL-6, P. aeruginosa infection also induced IL-10
expression but it was generally low except in one donor (Fig. 3B). Inflammasome activation
was indicated by the production of both IL-1β and IL-18 (Fig. 3C). Expression of IL-8, MCP-1,
MIP-1α TNF-α, IL-10 and IL-18, peaked at 4 hpi, while that of IL-6 and IL-1β expression con-
tinued to increase up to 6 hpi, which was the last time-point measured in this study. The exper-
iments were not continued beyond 6 hpi as widespread damage of the macrophage monolayer
was observed microscopically (see below).
Bacterial growth during infection was assessed to determine if macrophages could impact
on bacterial replication. Reduced viable bacteria were consistently observed at 2 to 4 hpi
(Fig. 4A). At 6 hpi a tendency towards increased bacterial growth was observed and, in two
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donors, the total bacteria in the presence of macrophages equalled or exceeded the bacteria in
control wells. Most bacteria were planktonic with only a small proportion detected in the cell-
associated fraction (Fig. 4A). Phagocytosis by macrophages was minimal probably due to the
absence of opsonins and low MOI used. Progressive macrophage death occurred, evidenced by
increasing LDH levels in supernatants and microscopic analysis of cells (Fig. 4B and C; S8
Fig.).
Thus, P. aeruginosa infection induced a robust pro-inflammatory cytokine response in un-
treated human macrophages. Macrophages temporarily restricted P. aeruginosa growth but
widespread macrophage death occurred in spite of the low MOI used.
GM-CSF in combination with IFN-γ enhances the pro-inflammatory
response of human macrophages to P. aeruginosa
To further investigate the contribution of human macrophages to the positive correlation be-
tween IFN-γ and lung function in CF in the context of P. aeruginosa infection, the ability of
Fig 3. Production of chemokines and cytokines by humanmacrophages upon infection with P. aeruginosa. Supernatants from uninfected and
infected macrophages (MOI = 1) were collected at 2, 4, and 6 hpi and tested for the presence of IL-8, MCP-1, and MIP-1α (A) TNF-α, IL-6 and IL-10 (B) and
IL-1β and IL-18 (C). IL-8 and MCP-1 were detected in supernatants from uninfected macrophages. All cytokines and chemokines tested were upregulated
upon PAO1-L infection, with most peaking at 4 hpi. Data presented are mean ± SD for n = 4 for all cytokines except IL-8 and IL-18 where n = 2. Significance
calculated by repeated measures one-way ANOVA with Tukey’s post test; * = p0.05, ** = p0.01, **** = p0.0001.
doi:10.1371/journal.pone.0117447.g003
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IFN-γ to enhance the response of macrophages to P. aeruginosa infection was studied. The
pro-inflammatory cytokine GM-CSF was used in addition to IFN-γ to treat macrophages.
Thus, four types of differentially activated macrophages were investigated in the present study:
untreated macrophages, macrophages treated with IFN-γ, macrophages treated with GM-CSF,
and macrophages treated with GM-CSF and IFN-γ. The effect of cytokine treatment on the in-
teraction of P. aeruginosa and human macrophages was studied at 4 hpi based on results ob-
tained with untreated macrophages (Fig. 3). The four types of differentially activated
macrophage populations differed in their ability to produce chemokines in the absence of in-
fection (Fig. 5). IFN-γ significantly increased constitutive MCP-1 expression (IFN-γ: p =
0.0106; GM-CSF and IFN-γ: p = 0.0098), while GM-CSF significantly increased constitutive
Fig 4. Humanmacrophages limit PAO1-L growth transiently but undergo significant cell death. A. Bacterial growth in the presence and absence of
macrophages was quantified at 2, 4, and 6 hpi. In the presence of macrophages, a significant reduction in total (significance reported as black asterisks) and
extracellular (significance reported as grey asterisks) PAO1-L was observed at 2 hpi (extracellular bacteria: p = 0.0005; total bacteria: p = 0.0022) and 4 hpi
(extracellular and total bacteria: p<0.0001), with maximum reduction at 4 hpi. However, this inhibition was transient and by 6 hpi there were no significant
differences between extracellular or total PAO1-L growth in the presence or absence of macrophages (extracellular bacteria: p = 0.5618; total bacteria: p =
0.8323). At all three time points bacteria in infected macrophage wells were predominantly planktonic rather than cell-associated. Data presented are mean ±
SD for n = 4. Significance was calculated by repeated measures one-way ANOVA with Dunnett’s post test; ** = p0.01, *** = p0.001, **** = p0.0001.
B. LDH release at 4 and 6 hpi by infected macrophages was significantly higher than by uninfected macrophages (4 hpi: p = 0.0072; 6 hpi: p = 0.0067). Data
presented are mean ± SD for n = 4. Significance calculated by a paired Student’s t test; ** = p0.01.C. Analysis of infected macrophage cultures by light
microscopy showed a monolayer of healthy, phenotypically heterogeneous macrophages with very few bacteria visible at 1 hpi. By 6 hpi, however, P.
aeruginosa dominated the culture and macrophages showed a reduction in the size of nuclei and disappearance of cytoplasm. Magnification = 400x.
doi:10.1371/journal.pone.0117447.g004
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IL-8 expression (GM-CSF: p = 0.0020; GM-CSF and IFN-γ: p<0.0001) (Fig. 5A). GM-CSF ap-
peared to have a minor effect on constitutive MCP-1 expression, with GM-CSF-treated macro-
phages producing approximately 2-fold more MCP-1 than untreated macrophages, but this
difference was not significant (p = 0.6700) (Fig. 5A). Hence, untreated macrophages produced
low MCP-1/low IL-8, macrophages treated with IFN-γ produced high MCP-1/low IL-8, mac-
rophages treated with GM-CSF produced moderate MCP-1/high IL-8, and macrophages treat-
ed with IFN-γ and GM-CSF produced high MCP-1/high IL-8 (Fig. 5A).
After P. aeruginosa infection IFN-γ significantly boosted MCP-1 production, regardless of
the presence of GM-CSF (IFN-γ: p = 0.0020; GM-CSF and IFN-γ: p = 0.0105) (Fig. 5A). In
Fig 5. Differential production of MCP-1 and IL-8 by macrophages under steady state and in response to P. aeruginosa infection upon activation
with IFN-γ in the presence and absence of GM-CSF.Macrophages were plated in X-Vivo 15, treated with IFN-γ in the presence and absence of GM-CSF
for 48 h and infected with PAO1-L for 4 h.A. IFN-γ activation significantly increased expression of MCP-1 in uninfected and PAO1-L-infected macrophages.
In contrast, constitutive IL-8 production was up-regulated by GM-CSF but was not significantly altered by macrophage activation after PAO1-L infection.
Dashed lines indicate significant differences between responses of uninfected macrophages; solid lines indicate significant differences between responses
of PAO1-L-infected macrophages. B. Fold increase in MCP-1 and IL-8 expression in infected macrophages compared with uninfected macrophages. Upon
infection the median IL-8 expression by untreated and IFN-γ-treated macrophages was up-regulated by 14-fold and 18-fold above baseline levels,
respectively, while that by macrophages treated with GM-CSF in the presence and absence of IFN-γ only increased by 3 to 4-fold above baseline levels. No
significant differences were observed in MCP-1 up-regulation among the four macrophage populations. Please note the differences in scale between the
lower (0–50) and higher values (50–350) in the graph representing IL-8 fold increase. Graphs depict 5–95 percentile with median for n = 4 to 8. Significance
calculated by one-way ANOVA with Tukey’s post test. * = p0.05, ** = p0.01, *** = p0.001, **** = p0.0001. Unt: untreated macrophages; (-):
uninfected; (+): infected.
doi:10.1371/journal.pone.0117447.g005
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contrast, macrophages produced equivalent amounts of IL-8 after infection irrespective of cy-
tokine treatment (Fig. 5A). Upon infection the median IL-8 expression by untreated macro-
phages and macrophages treated with IFN-γ was increased by 14-fold and 18-fold above
baseline levels, respectively, while that by macrophages treated with GM-CSF in the absence
and presence of IFN-γ only increased by 3 to 4-fold above baseline levels (Fig. 5B). These dif-
ferences in fold increases are consistent with the levelling of IL-8 production among the differ-
ent macrophage populations. In contrast, the fold increase in MCP-1 production upon P.
aeruginosa infection did not differ among the differentially activated macrophages (Fig. 5B).
IL-1β, IL-18, and MIP-1α expression in response to P. aeruginosa was not affected by macro-
phage activation (S9 Fig.).
Macrophage activation up-regulated TNF-α and IL-6 and down-regulated IL-10 production
upon PAO1-L infection and differences between the effects of IFN-γ and GM-CSF were ob-
served (Fig. 6A). TNF-α production was up-regulated approximately 2-fold by IFN-γ specifi-
cally; this was significant for macrophages treated with IFN-γ alone (p = 0.0378) (Fig. 6A). IL-6
production was weakly enhanced by IFN-γ or GM-CSF alone, but was significantly increased
when used in combination (p = 0.0287) (Fig. 6A). Finally, while treatment with IFN-γ or GM-
CSF alone did not reduce IL-10 production significantly (IFN-γ: ~11-fold, p = 0.0556; GM-
CSF: ~5-fold, p = 0.2084), both cytokines in combination caused a significant 72-fold reduction
Fig 6. Activation with IFN-γ in the presence and absence of GM-CSF enhances the pro-inflammatory cytokine profile of macrophages in response
to live P. aeruginosa.Macrophages were plated in X-Vivo 15, treated with IFN-γ in the presence and absence of GM-CSF for 48 h and infected with PAO1-L
for 4 h. A. Macrophage activation upregulated the production of TNF-α and IL-6 and downregulated IL-10 production in response to PAO1-L infection.
Negligible to no production of these cytokines was seen in uninfected macrophages under all activation conditions. B. Ratios of TNF-α vs. IL-10 and IL-6 vs
IL-10 revealed that the combination of IFN-γ and GM-CSF produced the most inflammatory macrophage population. In donors where IFN-γ activation
completely abrogated IL-10 expression, the minimum detectable limit of IL-10 for the assay (1.9 pg/ml) was used in order to calculate TNF-α/IL-10 and IL-6/
IL-10 ratios. Graphs depict 5–95 percentile with median for n = 6 to 8. Significance calculated by one-way ANOVA with Tukey’s post test; * = p0.05, ** =
p0.01. Unt: untreated macrophages; (-): uninfected; (+): infected.
doi:10.1371/journal.pone.0117447.g006
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(p = 0.0420) (Fig. 6A). In some donors, IL-10 was undetectable in infected cultures of macro-
phage treated with GM-CSF and IFN-γ. The effect of IFN-γ and GM-CSF on IL-6 expression
appeared additive, while on IL-10 expression it appeared synergistic. TNF-α vs. IL-10 and IL-6
vs. IL-10 ratios revealed the following hierarchy regarding the inflammatory potential of acti-
vated macrophages in response to P. aeruginosa infection: untreated< treated with GM-CSF
< treated with IFN-γ< treated with GM-CSF and IFN-γ (Fig. 6B). GM-CSF and IFN-γ did
not affect P. aeruginosa growth in X-Vivo 15 based on results from independent growth curves
and the quantification of cfu in bacteria-only control cultures done in parallel to macrophage
infections (S10 Fig.).
These results illustrate the complementary capabilities of IFN-γ and GM-CSF for modulat-
ing the inflammatory potential of human macrophages under steady state conditions and in re-
sponse to P. aeruginosa infection and support a role for macrophages in boosting
inflammation in response to P. aeruginosa during an IFN-γ-dominated response, particularly
in the presence of GM-CSF.
IFN-γ in the presence and absence of GM-CSF does not alter P.
aeruginosa growth or macrophage survival
Treatment with IFN-γ in the presence and absence of GM-CSF did not affect the ability of
human macrophages to restrict P. aeruginosa growth at 4 hpi. A consistent reduction in extra-
cellular bacteria was observed in the presence of macrophages, irrespective of donor or macro-
phage treatment (Fig. 7A). As shown in Fig. 4A, in most instances the cell-associated bacterial
fraction was minimal (Fig. 7B). However, in certain donors, extra growth of the cell-associated
fraction was observed and compensated for the reduction in the extracellular fraction, such
that in these cases the presence of macrophages did not affect the total amount of bacteria
(Fig. 7C). Finally, comparison of LDH concentrations in supernatants from infected macro-
phages at 4 hpi revealed that activation of macrophages with IFN-γ in the presence and absence
of GM-CSF did not significantly affect macrophage survival at this time point (IFN-γ: p =
0.9475; GM-CSF: p = 0.9438; GM-CSF and IFN-γ: p = 0.9001) (Fig. 7D). These results suggest
that the altered cytokine / chemokines responses obtained upon activation with IFN-γ in the
presence and absence of GM-CSF (Figs. 5 and 6) were not due to differences in cell survival or
bacterial load and that cellular activation does not protect macrophages from P. aeruginosa-in-
duced cytotoxicity nor affects P. aeruginosa growth in the presence of macrophages.
Discussion
Cytokine responses in CF PBMCs
This study corroborates the observation that systemic Th1 responses, based on levels of IFN-γ,
are reduced in CF patients [5–7]. The reduced IFN-γ production in CF PBMCs appeared to be
in response to general stimuli (PHA, SEB) rather than P. aeruginosa-specific (Fig. 1A). This
might be as a consequence of a higher number of P. aeruginosa-specific circulating helper T
cells in CF patients. In our study, both CF/Chronic PA and CF/Intermittent-Free PA PBMC
cultures yielded reduced IFN-γ in response to PHA or SEB. Other studies differ on whether
chronic P. aeruginosa infection correlates with IFN-γ responses. Brazova et al. reported similar
IFN-γ production in LPS- or PHA-stimulated whole blood cultures from CF children irrespec-
tive of P. aeruginosa status [36]. However, Moser et al. observed that P. aeruginosa outer mem-
brane protein (OMP)-stimulated PBMCs from P. aeruginosa-infected CF patients produced
significantly less IFN-γ than those from P. aeruginosa-negative CF patients [5]. Hartl et al.
found greater numbers of Th2 cells, higher levels of IL-4 and IL-13, and lower levels of IFN-γ
Response of Macrophages to P. aeruginosa in the Presence of IFN-Gamma
PLOSONE | DOI:10.1371/journal.pone.0117447 February 23, 2015 14 / 24
in the bronchoalveolar lavage of CF patients chronically infected with P. aeruginosa compared
to P. aeruginosa-free CF patients [7]. These discrepancies between studies may be due the use
of different patient cohorts and classification criteria for P. aeruginosa infection status. For in-
stance Moser et al. and Hartl et al. recruited patients who were free of P. aeruginosa infection
rather than those intermittently infected or free of P. aeruginosa as in the study presented here.
Robust Th1 responses to the mitogen PHA, correlated with better pulmonary status in CF pa-
tients, particularly in CF patients chronically infected with P. aeruginosa (Fig. 2). Moser et al.
reported a similar significant correlation in their cohort of CF patients chronically infected
with P. aeruginosa [5]. While reduced IFN-γ in CF samples is suggestive of a Th2 bias in CF
PBMCs, we did not observe increased production of the Th2-associated cytokine IL-13 (S5
Fig.), nor did we detect any correlation between IFN-γ and IL-13 levels in response to PHA,
SEB and PA Lo (data not shown). Our culture conditions did not support the detection of IL-4
but further work looking at IL-5 levels [18] could help to address this issue.
The reduced levels of IL-17A detected in CF cultures in response to all stimuli used (Fig. 1B)
were surprising based on previous reports in support of IL-17-driven inflammation in CF
Fig 7. IFN-γ activation in the presence and absence of GM-CSF did not affect macrophage survival or P. aeruginosa growth.Macrophages were
plated in X-Vivo 15, treated with IFN-γ in the presence and absence of GM-CSF for 48 h and infected with PAO1-L for 4 h. No significant differences were
observed in the percentage of extracellular (A), cell-associated (B), and total (C) bacterial growth among cultures of differentially activated infected
macrophages. The cell-associated fraction was found to be increased in certain donors. n = 6 to 10 for all bacterial growth data.D. Levels of LDH in infected
macrophage supernatants were not significantly affected by macrophage activation, n = 6 to 10. Significance was calculated by one-way ANOVA with
Tukey’s post test. Unt: untreated macrophages.
doi:10.1371/journal.pone.0117447.g007
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[14–18]. It could be argued that IL-17A production at peripheral sites might not correlate with
IL-17A produced by circulating immune cells upon stimulation; particularly because IL-17A-
producing cells might be recruited to the lung or peripheral lymph nodes [14]. Bayes et al. de-
tected Pseudomonas-specific Th1, Th17 and Th22 cells in both healthy and CF individuals and
observed reduced percentages of Th17 memory CD4+ T cells specific for P. aeruginosa in the
peripheral blood of CF patients compared to healthy controls [37]. Additionally IL-17A pro-
duction in the lung could be mediated by a variety of cells. For instance, Tams et al. identified
IL-17+ neutrophils, γδT cells and natural killer cells in addition to Th17 lymphocytes in bron-
chial biopsies of children with CF [17]. However our results are in clear disagreement with
studies that identified increased numbers of circulating IL-17A-producing T cells in CF pa-
tients [16,18] and the intrinsic predisposition of CF T cells to differentiate into Th17 cells re-
cently described [16].
The usefulness of IFN-γ and IL-17A production by PBMC as indicators of lung health in CF
may be limited by factors such as the stimulus used. PHA-induced IFN-γ and IL-17A produc-
tion in CF samples appears to be biologically relevant because of the positive and negative cor-
relations between lung function and PHA-induced IFN-γ and IL17A production, respectively,
observed for CF/Chronic PA samples (Fig. 2). In contrast IFN-γ and IL17A production in re-
sponse to SEB or PA Lo did not show any correlation with lung function (data not shown), in-
dicating a stimulus-dependent effect. While PHA induces polyclonal T cell activation in the
presence of soluble factors, such as IL-6, produced by accessory cells [38] this would not be the
case for SEB and P. aeruginosa lysate. The superantigen SEB is a toxin produced by Staphylo-
coccus aureus [39] that cross-links the T cell receptor (TCR) on αβT cells bearing particular Vβ
chains with non-cognate MHCmolecules, thus allowing promiscuous T cell activation [39].
SEB can activate up to 20% of all αβ T cells (predominantly CD4+ T cells) therefore only a sub-
population of T cells was being probed in our assays. SEB is also capable of engaging iNKT
cells through MHC class II, but not CD1d [40]. SEB requires expression of HLA-DR at the cell
surface of monocytes and P. aeruginosa lysates require antigen processing and presentation by
antigen presenting cells in the PBMC cultures. It is possible that CF monocytes could not effec-
tively support SEB and/or P. aeruginosa lysates-mediated lymphocyte activation as they have
been shown to express reduced levels of MHCII and might be impaired in antigen presentation
[41].
Investigation of the behaviour of human PBMCs in vitro offers a useful non-invasive tool to
assess the immune status of patients and its relationship with disease. In general, PBMC cul-
tures are normalised for total viable cells which does not take into account potential differences
in cellular composition. In this regard it is pertinent to refer to a recent work by Rieber et al. de-
scribing increased numbers of myeloid-derived suppressor cells (MDSC) in PBMCs of CF pa-
tients [42]. These potent immunosuppressive cells [43] were preferentially present in patients
chronically infected with P. aeruginosa, in particular those infected with non-mucoid strains,
and their percentage in total PBMCs from CF patients varied from less than 1% to 20%. Fur-
thermore, the presence of MDSC correlated with improved lung function in CF patients in-
fected with P. aeruginosa. CF-MDSC dampened production of several cytokines, chemokines
and growth factors in stimulated PBMC cultures including IL-17A, IFN-γ, IL-13, IL-6, GM-
CSF and IL-10 [42]. We propose that differences in patient characteristics, and in turn the cel-
lular composition of the PBMC preparations such as T and B cell subsets [44,45], might ac-
count for some of the discrepancies observed, particularly in the case of IL-17A production.
Two issues need to be taken into consideration: (i) the mean age of the cohort (6.1 in the case
of Tiringer et al [18], 16 in the case of Rieber et al [42] vs. 27 in this study) as older patients,
who would have been exposed to chronic inflammatory conditions for longer might have in-
creased numbers of MDSC in circulation [46] and (ii) the type of P. aeruginosa isolates (e.g.
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flagellated vs. non-flagellated) as infection with flagellated P. aeruginosa was associated with
MDSC induction in CF patients and flagellum induced the generation of MDSC [42].
The potential contribution of human macrophages to maintenance of
lung function during IFN-γ-dominated immune responses in the context
of P. aeruginosa infection
In the study presented here it was next questioned how IFN-γ could positively impact on lung
function in CF patients (Fig. 2). Preservation of organ function during infection results from a
delicate balance between pro-inflammatory processes that promote clearance of infectious
agents but have the potential to cause substantial tissue damage, and anti-inflammatory pro-
cesses, aimed at minimising tissue damage and promote resolution that could compromise
anti-microbial immunity. Thus IFN-γ could be beneficial in CF by promoting an inflammatory
response capable of controlling infection while minimising lung damage. Macrophages play a
central role in the regulation of inflammation and it was hypothesised that investigation of the
effect of IFN-γ on the behaviour of macrophages during P. aeruginosa infection could provide
information regarding the potential benefits of an IFN-γ-driven inflammatory response against
P. aeruginosa. GM-CSF was included in the study because of its established activating effect on
myeloid cell function [28,29] and the reported correlation between high serum GM-CSF with
increased IFN-γ expression and better pulmonary function in CF patients [6]. Also, recent pub-
lications indicate that GM-CSF production by Th17 cells is responsible for their pathological
role during chronic inflammation [47,48]. Although there are clear limitations when trying to
translate in vitro findings to in vivo conditions it is possible to speculate regarding the biologi-
cal consequences of the work presented here and make predictions that can be tested using
more complex systems or clinical samples.
This manuscript shows that the response of macrophages to P. aeruginosa infection can be
modulated by IFN-γ and GM-CSF and that both cytokines synergise to increase the inflamma-
tory potential of macrophages in response to P. aeruginosa. In particular macrophages treated
with IFN-γ produce more TNF-α and less IL-10 in response to P. aeruginosa infection than un-
treated macrophages and macrophages treated with GM-CSF. GM-CSF synergises with IFN-γ
in reducing IL-10 synthesis by macrophages in response to infection. Hence it is possible that
exposure of macrophages to IFN-γ and GM-CSF in the lung could trigger an aggressive inflam-
matory response characterised by high TNF-α/IL-10 and IL-6/IL-10 ratios (Fig. 6B) that pro-
motes tissue damage. In agreement with this idea GM-CSF can be expressed in association
with IFN-γ by human T cells during chronic inflammation [49]. The drastic reduction in IL-10
production induced by IFN-γ and GM-CSF could also be linked to the detrimental role of IL-
17A in CF. GM-CSF can be produced by Th17 cells and if we consider IL-17A as a surrogate
marker for the presence of GM-CSF, it could be speculated that the negative correlation be-
tween IL-17A levels and lung function in CF (Fig. 2) could be potentially caused by increased
levels of GM-CSF in these patients. Further work would benefit from the identification of T cell
subsets in the lungs of CF patients with and without P. aeruginosa infection with particular
focus on T cells that co-express IFN-γ and GM-CSF and their relation to Th17 cells [49].
IFN-γ and GM-CSF can induce chemokine production in cultures of uninfected macro-
phages (Fig. 5); IFN-γ enhanced constitutive expression of the monocyte chemoattractant
MCP-1 (Fig. 5), while GM-CSF upregulated the neutrophil chemoattractant IL-8. Each macro-
phage population under investigation appeared to produce a distinct chemokine pattern in the
absence of infection: untreated macrophages low MCP-1/low IL-8, macrophages treated with
IFN-γ high MCP-1/low IL-8, macrophages treated with GM-CSF moderate MCP-1/high IL-8,
and macrophages treated with IFN-γ and GM-CSF high MCP-1/high IL-8. Hence,
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macrophages exposed to IFN-γ or GM-CSF could recruit monocytes and/or neutrophils, even
before encountering a pathogen. In infected macrophages treatment with IFN-γ in the presence
or absence of GM-CSF did not affect the production of IL-8 indicating that neutrophil recruit-
ment might not be affected by these cytokines during infection. On the other hand, IFN-γ
treatment could promote recruitment of monocytes by infected macrophages regardless of the
presence of GM-CSF which might limit tissue destruction caused by neutrophils. The results
from the present manuscript are in agreement with a previous report on the differential regula-
tion of IL-8 and MCP-1 expression in human macrophages, with MCP-1 synthesis being in-
duced in response to IFN-γ and IL-8 in response to LPS [50,51].
Activation with IFN-γ in the presence and absence of GM-CSF did not alter the production
of the inflammasome-associated cytokines IL-1β or IL-18 (S9 Fig.). This is relevant in the con-
text of P. aeruginosa respiratory infections as it has been demonstrated in murine acute P. aeru-
ginosa pneumonia models that IL-1β and IL-18 released upon alveolar macrophage
inflammasome activation are deleterious for the host [52–54]. Cellular responses to IFN-γ and
GM-CSF are dominated by STAT-1 [55] and STAT-5 [56], respectively, with both cytokines
conferring a ‘primed state’ to macrophages that enhances their ability to respond to stimula-
tion. It would be of interest to characterise the interplay between the signalling pathways trig-
gered by IFN-γ and GM-CSF in order to determine the molecular basis for their additive and
synergistic effects with particular emphasis on how they cooperate to regulate IL-
10 expression.
Macrophages could potentially control the growth of P. aeruginosa through phagocytosis,
production of reactive oxygen species, release of hydrolases and iron sequestration [57,58].
Macrophage activation with IFN-γ in the presence and absence of GM-CSF did not affect bac-
terial growth or protect macrophages from P. aeruginosa-induced cytotoxicity (Figs. 4B-C and
7D). Hence, an IFN-γ-dominated (Th1) immune response is unlikely to safeguard lung func-
tion by promoting the ability of macrophages to control P. aeruginosa infection or by increas-
ing resistance of macrophages to the cytotoxic effect of P. aeruginosa. This is in agreement with
a previous study describing a negative effect of IFN-γ on the phagocytosis and killing of P. aer-
uginosa by human macrophages [59]. The inability of macrophages treated with GM-CSF to
restrict P. aeruginosa growth contrasts with the role played by this cytokine in protection
against lethal P. aeruginosa pneumonia in vaccinated neutropenic mice [60]. It is possible that
the protective role of GM-CSF in the murine pneumonia model could be facilitated by the pres-
ence of opsonins such as antibodies specific for P. aeruginosa or lung collectins, such as SP-A,
which could promote phagocytic uptake and cellular activation, or the accumulation of mono-
cytes/macrophages in the infected lungs of vaccinated animals [60].
There was also the possibility of P. aeruginosa changing to a senescent growth programme
in the presence of macrophages as radical oxygen species and anti-microbial peptides have
been shown to promote mucoidy in P. aeruginosa in vitro [61]. To address this, planktonic and
cell-associated bacteria were quantified independently after infection. Microscopic analysis of
infected cultures showed stepwise destruction of the macrophage monolayer with bacterial
microcolonies observed within areas of cellular damage surrounded by healthy cells (S8 Fig.).
This suggests that macrophage death was mediated by direct bacterial contact [62] and that se-
creted virulence factors might have not reached cytotoxic concentrations. Macrophage death in
most cases correlated with the total bacterial burden (data not shown). The high expression of
IL-1β and IL-18 (Fig. 3C and S9 Fig.) and nuclear condensation observed at 6 hpi (Fig. 4C) sug-
gest that macrophages died by pyroptosis (inflammatory cell death caused by caspase-1 activa-
tion [63]). This would agree with other reports of P. aeruginosa type 3 secretion system
inducing pyroptosis in macrophages via activation of the NLRC4 inflammasome [62]. Micro-
colony formation in the current study indicates transition from planktonic to sessile growth
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and might account for the increased cell-associated growth of P. aeruginosa in several experi-
ments (Fig. 7B). Preliminary evidence suggests this may be donor-dependent. We propose that
these changes in bacterial behaviour could be caused by the inflammatory conditions prevalent
in these particular infections and be related to the levels of reactive oxygen species or anti-mi-
crobial peptides present [61].
In conclusion, we have observed that IFN-γ production by CF PBMCs positively correlated
with lung function, particularly in patients chronically infected with P. aeruginosa, while IL-
17A levels tended to correlate negatively with lung function, with this trend becoming signifi-
cant in patients chronically infected with P. aeruginosa. These results are in agreement with
IFN-γ and IL-17A playing protective and detrimental roles, respectively, in CF. In addition,
our study provides information regarding parameters that need to be taken into consideration
when looking at systemic immune responses in clinical samples. For instance, our results illus-
trate the importance of the stimuli used for activation of immune cells. Stimuli that require
support from antigen presenting cells for T cell activation in the form of cytokines and/or high
surface MHCII expression would provide a more comprehensive evaluation of the immunolog-
ical status of patients as T cell responses are highly dependent on the activation state of antigen
presenting cells. This would be lost when employing anti-CD3 and CD28 antibodies to stimu-
late T cells which would induce polyclonal activation of all T cells but will only allow the analy-
sis of the potential levels of T cell-derived cytokines that can be produced in patients.
Results using human macrophages infected with P. aeruginosa indicate that IFN-γmight
promote an inflammatory response characterised by a balanced production of pro- and anti-
inflammatory cytokines and recruitment of mononuclear cells. This is agreement with early
work showing the ability of IFN-γ to decrease the inflammatory response in chronic P. aerugi-
nosa pneumonia in rats [8]. In contrast IFN-γ in combination with GM-CSF might promote
tissue damage because of a reduced anti-inflammatory response, unable to safeguard tissues
from the deleterious effects of inflammation.
Future work in this area will benefit from the use of isolated tissue macrophages from
healthy donors and CF patients and clinical isolates of P. aeruginosa. It would also be pertinent
to investigate the effect of macrophage-derived cytokines and other inflammatory mediators
on other immune cells such as neutrophils. Particular emphasis should be placed in establish-
ing activation regimes consisting of specific combinations of effector cytokines that promote
the microbicidal capabilities of immune cells but minimise the potential for tissue damage. Co-
cultures of phagocytes (macrophages and neutrophils) exposed to different combination of cy-
tokines would provide a highly valuable tool to perform preclinical studies towards this aim.
Supporting Information
S1 Fig. Characterisation of human monocyte-derived macrophages differentiated in sus-
pension (Teflon bottles) for 7 days. A. CD68 and mannose receptor (MR) expression in mac-
rophages demonstrated by immunofluorescence. B. Flow cytometric analysis showed that
CD14, CD16, HLA-DR, and MR surface expression was significantly upregulated upon mono-
cyte (open circles) differentiation into macrophages (open squares). MFI = mean fluorescence
intensity. Significance was calculated by unpaired Student’s t test for CD14, HLA-DR, and
mannose receptor, and Mann-Whitney test for CD16. C. Reactive oxygen species production
by zymosan-stimulated macrophages differentiated in M-CSF or GM-CSF.
(TIF)
S2 Fig. PAO1-L growth in LB broth and X-Vivo 15 is similar under oxygenated conditions.
PAO1-L was cultured in LB broth or X-Vivo 15 at 37°C, 200 rpm and OD600nm of the cultures
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measured at the times indicated.
(TIF)
S3 Fig. PAO1-N expresses quorum sensing molecules and virulence factors in X-Vivo 15
but the las and rhl systems are lower than in LB. PAO1-N (Nottingham subline) reporter
strains carrying lux promoter fusions (see S1 Table) were used to determine the expression of
quorum sensing and virulence factor genes in LB broth and X-Vivo 15. Luminescence and
OD600nm were measured for each culture every 30 min. To negate any differences in lumines-
cence due to differences in growth of the reporter strains, gene expression was reported as lu-
minescence (relative light units, RLU) divided by OD600nm for that culture. Only every second
data point is plotted for ease of viewing. Data presented are mean of three independent experi-
ments. Bacterial strains are described in S1 Table.
(TIF)
S4 Fig. LDH released by PAO1-L upon freezing and thawing and sonication to lyse cells.
Three independently prepared mid-log phase cultures of PAO1-L in X-Vivo 15 at a density of
5 x 108 cfu/ml (which was much higher than the total bacterial load ever achieved in any of the
in vitro infection assays used in this study) released on average only 12.2 ± 3.6 ng/ml LDH
(mean ± SD, n = 3) upon freezing and thawing followed by sonication.
(TIF)
S5 Fig. IL-13 (A) and IL-10 (B) production by healthy and CF PBMCs stimulated with
PHA, SEB or P. aeruginosa lysates. Graphs depict 5–95 percentile with median. For IL-10 (all
stimuli), Healthy controls: n = 13, CF / Intermittent-Free PA and CF / Chronic PA: n = 15. For
IL-13 (SEB, PA Hi, PA Lo), Healthy controls: n = 13, CF / Intermittent-Free PA: n = 15, CF /
Chronic PA: n = 11, while for IL-13 (PHA): Healthy controls: n = 7, CF / Intermittent-Free PA:
n = 13, CF / Chronic PA: n = 9 as IL-13 production by the remaining donors under this condi-
tion was above the standard range of the assay. Significance calculated by Kruskal-Wallis test
with Dunn’s post test.  = p0.05,  = p0.01.
(TIF)
S6 Fig. Lung function in CF patients. CF / Intermittent-Free PA patients demonstrated signif-
icantly better lung function than CF / Chronic PA patients. This was particularly evident when
pulmonary function was described as a percentage of predicted FEV1. Data presented are
mean ± SD. Significance calculated by an unpaired Student’s t test.
(TIF)
S7 Fig. Correlation between lung function and IFN-γ and IL-17A production in response
to PHA in CF / Intermittent-Free PA patients. Correlation between IFN-γ and IL-17A pro-
duction in response to PHA and lung function was non-significant in the subset of intermit-
tent-free CF patients. Correlation calculated by Spearman rank test.
(TIF)
S8 Fig. Analysis of PAO1-L-infected macrophage cultures by light microscopy. PAO1-L
clusters can be observed at 2 hpi (black arrows) and increase in number and size at later times
post-infection. Magnification = 400x.
(TIF)
S9 Fig. Activation of human macrophages with IFN-γ in the presence and absence of GM-
CSF does not significantly alter the expression of IL-1β, IL-18, and MIP-1α in response to
PAO1-L at 4 hpi. Significance was calculated by one-way ANOVA with Tukey’s post test. IL-
1β: p = 0.8320, n = 6 for +/- IFN-γ and n = 4 for GM-CSF +/- IFN-γ. IL-18: p = 0.9582, n = 6
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for IFN-γ, n = 4 for GM-CSF +/- IFN-γ. MIP-1α: p = 0.3786, n = 6 for +/- IFN-γ and n = 4 for
GM-CSF +/- IFN-γ. Unt: untreated controls.
(TIF)
S10 Fig. PAO1-L growth in X-Vivo 15 under stationary conditions is not affected by the ad-
dition of macrophage-activating cytokines. A. Bacteria were cultured in a 96-well microtitre
plate at 37°C for 24 h in a Tecan Infinite M1000 PRO plate reader which measured the absor-
bance (OD600nm) of the cultures every 30 min. Only every second data point is plotted for ease
of viewing. Data presented are mean ± SD for two experiments. B. Number of cfu in bacteria
only wells at 4 hpi during macrophage infection assays. No significant difference was observed
in the presence of different cytokines (p = 0.4890, one-way ANOVA with Tukey’s post test).
(TIF)
S1 Table. P. aeruginosa strains used in this study.
(TIF)
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